Functional MAPT haplotypes: Bridging the gap between genotype and neuropathology

Neurobiology of Disease

Volumn 27, Issue 1, 2007, Pages 1-10

  Caffrey, Tara M ^a   Wade Martins, Richard ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Functional polymorphisms; Gene expression; H1 haplotype; MAPT; Progressive supranuclear palsy; Splicing; Susceptibility mechanisms; Tauopathy

Indexed keywords

TAU PROTEIN;

ALZHEIMER DISEASE; CORTICOBASAL DEGENERATION; DEGENERATIVE DISEASE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; MAPT GENE; NEUROPATHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

ALTERNATIVE SPLICING; BASE SEQUENCE; HAPLOTYPES; HUMANS; TAU PROTEINS; TAUOPATHIES;

EID: 34250335127     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2007.04.006     Document Type: Review

References (76)

1. Andreadis A., Brown W.M., and Kosik K.S. Structure and novel exons of the human tau gene. Biochemistry (Mosc.) 31 43 (1992) 10626-10633
2. Arai T., Ikeda K., Akiyama H., Shikamoto Y., Tsuchiya K., Yagishita S., Beach T., Rogers J., Schwab C., and McGeer P.L. Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol. (Berl.) 101 2 (2001) 167-173
3. Baker M., Litvan I., Houlden H., Adamson J., Dickson D., Perez-Tur J., Hardy J., Lynch T., Bigio E., and Hutton M. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum. Mol. Genet. 8 4 (1999) 711-715
4. Brandt R., Leger J., and Lee G. Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain. J. Cell Biol. 131 5 (1995) 1327-1340
5. Bray N.J., Buckland P.R., Williams N.M., Williams H.J., Norton N., Owen M.J., and O'Donovan M.C. A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. Am. J. Hum. Genet. 73 1 (2003) 152-161
6. Bray N.J., Jehu L., Moskvina V., Buxbaum J.D., Dracheva S., Haroutunian V., Williams J., Buckland P.R., Owen M.J., and O'Donovan M.C. Allelic expression of APOE in human brain: effects of epsilon status and promoter haplotypes. Hum. Mol. Genet. 13 22 (2004) 2885-2892
7. Bray N.J., Preece A., Williams N.M., Moskvina V., Buckland P.R., Owen M.J., and O'Donovan M.C. Haplotypes at the dystrobrevin binding protein 1 (DTNBP1) gene locus mediate risk for schizophrenia through reduced DTNBP1 expression. Hum. Mol. Genet. 14 14 (2005) 1947-1954
8. Buee Scherrer V., Hof P.R., Buee L., Leveugle B., Vermersch P., Perl D.P., Olanow C.W., and Delacourte A. Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick's disease. Acta Neuropathol. (Berl.) 91 4 (1996) 351-359
9. Caffrey T.M., Joachim C., Paracchini S., Esiri M.M., and Wade-Martins R. Haplotype-specific expression of exon 10 at the human MAPT locus. Hum. Mol. Genet. 15 24 (2006) 3529-3537
10. Carmel G., Mager E.M., Binder L.I., and Kuret J. The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology. J. Biol. Chem. 271 51 (1996) 32789-32795
11. Chambers C.B., Lee J.M., Troncoso J.C., Reich S., and Muma N.A. Overexpression of four-repeat tau mRNA isoforms in progressive supranuclear palsy but not in Alzheimer's disease. Ann. Neurol. 46 3 (1999) 325-332
12. Chen J., Kanai Y., Cowan N.J., and Hirokawa N. Projection domains of MAP2 and tau determine spacings between microtubules in dendrites and axons. Nature 360 6405 (1992) 674-677
13. Connell J.W., Rodriguez-Martin T., Gibb G.M., Kahn N.M., Grierson A.J., Hanger D.P., Revesz T., Lantos P.L., Anderton B.H., and Gallo J.M. Quantitative analysis of tau isoform transcripts in sporadic tauopathies. Brain Res. Mol. Brain Res. 137 1-2 (2005) 104-109
14. Conrad C., Andreadis A., Trojanowski J.Q., Dickson D.W., Kang D., Chen X., Wiederholt W., Hansen L., Masliah E., Thal L.J., et al. Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann. Neurol. 41 2 (1997) 277-281
15. Conrad C., Amano N., Andreadis A., Xia Y., Namekataf K., Oyama F., Ikeda K., Wakabayashi K., Takahashi H., Thal L.J., et al. Differences in a dinucleotide repeat polymorphism in the tau gene between Caucasian and Japanese populations: implication for progressive supranuclear palsy. Neurosci. Lett. 250 2 (1998) 135-137
16. Crowther R.A. Structural aspects of pathology in Alzheimer's disease. Biochim. Biophys. Acta 1096 1 (1990) 1-9
17. Cruts M., Rademakers R., Gijselinck I., van der Zee J., Dermaut B., de Pooter T., de Rijk P., Del-Favero J., and van Broeckhoven C. Genomic architecture of human 17q21 linked to frontotemporal dementia uncovers a highly homologous family of low-copy repeats in the tau region. Hum. Mol. Genet. 14 13 (2005) 1753-1762
18. D'Souza I., and Schellenberg G.D. Determinants of 4-repeat tau expression. Coordination between enhancing and inhibitory splicing sequences for exon 10 inclusion. J. Biol. Chem. 275 23 (2000) 17700-17709
19. D'Souza I., and Schellenberg G.D. tau Exon 10 expression involves a bipartite intron 10 regulatory sequence and weak 5′ and 3′ splice sites. J. Biol. Chem. 277 29 (2002) 26587-26599
20. D'Souza I., and Schellenberg G.D. Regulation of tau isoform expression and dementia. Biochim. Biophys. Acta 1739 2-3 (2005) 104-115
21. D'Souza I., and Schellenberg G.D. Arginine/serine-rich protein interaction domain-dependent modulation of a tau exon 10 splicing enhancer: altered interactions and mechanisms for functionally antagonistic FTDP-17 mutations Delta280K and N279K. J. Biol. Chem. 281 5 (2006) 2460-2469
22. D'Souza I., Poorkaj P., Hong M., Nochlin D., Lee V.M., Bird T.D., and Schellenberg G.D. Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. Proc. Natl. Acad. Sci. U. S. A. 96 10 (1999) 5598-5603
23. Delacourte A., Robitaille Y., Sergeant N., Buee L., Hof P.R., Wattez A., Laroche-Cholette A., Mathieu J., Chagnon P., and Gauvreau D. Specific pathological Tau protein variants characterize Pick's disease. J. Neuropathol. Exp. Neurol. 55 2 (1996) 159-168
24. de Silva R., Weiler M., Morris H.R., Martin E.R., Wood N.W., and Lees A.J. Strong association of a novel Tau promoter haplotype in progressive supranuclear palsy. Neurosci. Lett. 311 3 (2001) 145-148
25. Di Maria E., Tabaton M., Vigo T., Abbruzzese G., Bellone E., Donati C., Frasson E., Marchese R., Montagna P., Munoz D.G., et al. Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy. Ann. Neurol. 47 3 (2000) 374-377
26. Donahue C.P., Muratore C., Wu J.Y., Kosik K.S., and Wolfe M.S. Stabilization of the tau exon 10 stem loop alters pre-mRNA splicing. J. Biol. Chem. 281 33 (2006) 23302-23306
27. Evans W., Fung H.C., Steele J., Eerola J., Tienari P., Pittman A., Silva R., Myers A., Vrieze F.W., Singleton A., et al. The tau H2 haplotype is almost exclusively Caucasian in origin. Neurosci. Lett. 369 3 (2004) 183-185
28. Ferri C.P., Prince M., Brayne C., Brodaty H., Fratiglioni L., Ganguli M., Hall K., Hasegawa K., Hendrie H., Huang Y., et al. Global prevalence of dementia: a Delphi consensus study. Lancet 366 9503 (2005) 2112-2117
29. Gao Q.S., Memmott J., Lafyatis R., Stamm S., Screaton G., and Andreadis A. Complex regulation of tau exon 10, whose missplicing causes frontotemporal dementia. J. Neurochem. 74 2 (2000) 490-500
30. Goedert M., Wischik C.M., Crowther R.A., Walker J.E., and Klug A. Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. Proc. Natl. Acad. Sci. U. S. A. 85 11 (1988) 4051-4055
31. Goedert M., Spillantini M.G., Jakes R., Rutherford D., and Crowther R.A. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3 4 (1989) 519-526
32. Goedert M., Spillantini M.G., Potier M.C., Ulrich J., and Crowther R.A. Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J. 8 2 (1989) 393-399
33. Grover A., Houlden H., Baker M., Adamson J., Lewis J., Prihar G., Pickering-Brown S., Duff K., and Hutton M. 5′ splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10. J. Biol. Chem. 274 21 (1999) 15134-15143
34. Grover A., DeTure M., Yen S.H., and Hutton M. Effects on splicing and protein function of three mutations in codon N296 of tau in vitro. Neurosci. Lett. 323 1 (2002) 33-36
35. Gustke N., Trinczek B., Biernat J., Mandelkow E.M., and Mandelkow E. Domains of tau protein and interactions with microtubules. Biochemistry (Mosc.) 33 32 (1994) 9511-9522
36. Hasegawa M., Smith M.J., Iijima M., Tabira T., and Goedert M. FTDP-17 mutations N279K and S305N in tau produce increased splicing of exon 10. FEBS Lett. 443 2 (1999) 93-96
37. Houlden H., Baker M., Morris H.R., MacDonald N., Pickering-Brown S., Adamson J., Lees A.J., Rossor M.N., Quinn N.P., Kertesz A., et al. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology 56 12 (2001) 1702-1706
38. Hutton M., Lendon C.L., Rizzu P., Baker M., Froelich S., Houlden H., Pickering-Brown S., Chakraverty S., Isaacs A., Grover A., et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393 6686 (1998) 702-705
39. Jiang Z., Cote J., Kwon J.M., Goate A.M., and Wu J.Y. Aberrant splicing of tau pre-mRNA caused by intronic mutations associated with the inherited dementia frontotemporal dementia with parkinsonism linked to chromosome 17. Mol. Cell. Biol. 20 11 (2000) 4036-4048
40. Jiang Z., Tang H., Havlioglu N., Zhang X., Stamm S., Yan R., and Wu J.Y. Mutations in tau gene exon 10 associated with FTDP-17 alter the activity of an exonic splicing enhancer to interact with Tra2 beta. J. Biol. Chem. 278 21 (2003) 18997-19007
41. Kidd M. Paired helical filaments in electron microscopy of Alzheimer's disease. Nature 197 (1963) 192-193
42. Knight J.C. Allele-specific gene expression uncovered. Trends Genet. 20 3 (2004) 113-116
43. Kondo S., Yamamoto N., Murakami T., Okumura M., Mayeda A., and Imaizumi K. Tra2 beta, SF2/ASF and SRp30c modulate the function of an exonic splicing enhancer in exon 10 of tau pre-mRNA. Genes Cells 9 2 (2004) 121-130
44. Koolen D.A., Vissers L.E., Pfundt R., de Leeuw N., Knight S.J., Regan R., Kooy R.F., Reyniers E., Romano C., and Fichera M. A new chromosome 17q21.31 microdeletion syndrome associated with a common inversion polymorphism. Nat. Genet. 38 9 (2006) 999-1001
45. Kwok J.B., Teber E.T., Loy C., Hallupp M., Nicholson G., Mellick G.D., Buchanan D.D., Silburn P.A., and Schofield P.R. Tau haplotypes regulate transcription and are associated with Parkinson's disease. Ann. Neurol. 55 3 (2004) 329-334
46. Morris H.R., Janssen J.C., Bandmann O., Daniel S.E., Rossor M.N., Lees A.J., and Wood N.W. The tau gene A0 polymorphism in progressive supranuclear palsy and related neurodegenerative diseases. J. Neurol. Neurosurg. Psychiatry 66 5 (1999) 665-667
47. Myers A.J., Pittman A.M., Zhao A.S., Rohrer K., Kaleem M., Marlowe L., Lees A., Leung D., McKeith I.G., Perry R.H., et al. The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts. Neurobiol. Dis. 25 3 (2007) 561-570
48. Oliva R., Tolosa E., Ezquerra M., Molinuevo J.L., Valldeoriola F., Burguera J., Calopa M., Villa M., and Ballesta F. Significant changes in the tau A0 and A3 alleles in progressive supranuclear palsy and improved genotyping by silver detection. Arch. Neurol. 55 8 (1998) 1122-1124
49. Paracchini S., Thomas A., Castro S., Lai C., Paramasivam M., Wang Y., Keating B.J., Taylor J.M., Hacking D.F., and Scerri T. The chromosome 6p22 haplotype associated with dyslexia reduces the expression of KIAA0319, a novel gene involved in neuronal migration. Hum. Mol. Genet. 15 10 (2006) 1659-1666
50. Pastor P., Pastor E., Carnero C., Vela R., Garcia T., Amer G., Tolosa E., and Oliva R. Familial atypical progressive supranuclear palsy associated with homozygosity for the delN296 mutation in the tau gene. Ann. Neurol. 49 2 (2001) 263-267
51. Pastor P., Ezquerra M., Tolosa E., Munoz E., Marti M.J., Valldeoriola F., Molinuevo J.L., Calopa M., and Oliva R. Further extension of the H1 haplotype associated with progressive supranuclear palsy. Mov. Disord. 17 3 (2002) 550-556
52. Pittman A.M., Myers A.J., Duckworth J., Bryden L., Hanson M., Abou-Sleiman P., Wood N.W., Hardy J., Lees A., and de Silva R. The structure of the tau haplotype in controls and in progressive supranuclear palsy. Hum. Mol. Genet. 13 12 (2004) 1267-1274
53. Pittman A.M., Myers A.J., Abou-Sleiman P., Fung H.C., Kaleem M., Marlowe L., Duckworth J., Leung D., Williams D., Kilford L., et al. Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration. J. Med. Genet. 42 11 (2005) 837-846
54. Poorkaj P., Muma N.A., Zhukareva V., Cochran E.J., Shannon K.M., Hurtig H., Koller W.C., Bird T.D., Trojanowski J.Q., Lee V.M., et al. An R5L tau mutation in a subject with a progressive supranuclear palsy phenotype. Ann. Neurol. 52 4 (2002) 511-516
55. Powell H.C., London G.W., and Lampert P.W. Neurofibrillary tangles in progressive supranuclear palsy. Electron microscopic observations. J. Neuropathol. Exp. Neurol. 33 1 (1974) 98-106
56. Rademakers R., Melquist S., Cruts M., Theuns J., Del-Favero J., Poorkaj P., Baker M., Sleegers K., Crook R., De Pooter T., et al. High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy. Hum. Mol. Genet. 14 21 (2005) 3281-3292
57. Redon R., Ishikawa S., Fitch K.R., Feuk L., Perry G.H., Andrews T.D., Fiegler H., Shapero M.H., Carson A.R., Chen W., et al. Global variation in copy number in the human genome. Nature 444 7118 (2006) 444-454
58. Rizzu P., Van Swieten J.C., Joosse M., Hasegawa M., Stevens M., Tibben A., Niermeijer M.F., Hillebrand M., Ravid R., Oostra B.A., et al. High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. Am. J. Hum. Genet. 64 2 (1999) 414-421
59. Ros R., Thobois S., Streichenberger N., Kopp N., Sanchez M.P., Perez M., Hoenicka J., Avila J., Honnorat J., and de Yebenes J.G. A new mutation of the tau gene, G303V, in early-onset familial progressive supranuclear palsy. Arch. Neurol. 62 9 (2005) 1444-1450
60. Sergeant N., David J.P., Lefranc D., Vermersch P., Wattez A., and Delacourte A. Different distribution of phosphorylated tau protein isoforms in Alzheimer's and Pick's diseases. FEBS Lett. 412 3 (1997) 578-582
61. Shahani N., and Brandt R. Functions and malfunctions of the tau proteins. Cell. Mol. Life Sci. 59 10 (2002) 1668-1680
62. Shaw-Smith C., Pittman A.M., Willatt L., Martin H., Rickman L., Gribble S., Curley R., Cumming S., Dunn C., Kalaitzopoulos D., et al. Microdeletion encompassing MAPT at chromosome 17q21.3 is associated with developmental delay and learning disability. Nat. Genet. 38 9 (2006) 1032-1037
63. Spillantini M.G., Murrell J.R., Goedert M., Farlow M.R., Klug A., and Ghetti B. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc. Natl. Acad. Sci. U. S. A. 95 13 (1998) 7737-7741
64. Spillantini M.G., Yoshida H., Rizzini C., Lantos P.L., Khan N., Rossor M.N., Goedert M., and Brown J. A novel tau mutation (N296N) in familial dementia with swollen achromatic neurons and corticobasal inclusion bodies. Ann. Neurol. 48 6 (2000) 939-943
65. Stanford P.M., Halliday G.M., Brooks W.S., Kwok J.B., Storey C.E., Creasey H., Morris J.G., Fulham M.J., and Schofield P.R. Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: expansion of the disease phenotype caused by tau gene mutations. Brain 123 Pt 5 (2000) 880-893
66. Stanford P.M., Shepherd C.E., Halliday G.M., Brooks W.S., Schofield P.W., Brodaty H., Martins R.N., Kwok J.B., and Schofield P.R. Mutations in the tau gene that cause an increase in three repeat tau and frontotemporal dementia. Brain 126 Pt 4 (2003) 814-826
67. Stefansson H., Helgason A., Thorleifsson G., Steinthorsdottir V., Masson G., Barnard J., Baker A., Jonasdottir A., Ingason A., Gudnadottir V.G., et al. A common inversion under selection in Europeans. Nat. Genet. 37 2 (2005) 129-137
68. Takanashi M., Mori H., Arima K., Mizuno Y., and Hattori N. Expression patterns of tau mRNA isoforms correlate with susceptible lesions in progressive supranuclear palsy and corticobasal degeneration. Brain Res. Mol. Brain Res. 104 2 (2002) 210-219
69. Tellez-Nagel I., and Wisniewski H.M. Ultrastructure of neurofibrillary tangles in Steele-Richardson-Olszewski syndrome. Arch. Neurol. 29 5 (1973) 324-327
70. Togo T., Sahara N., Yen S.H., Cookson N., Ishizawa T., Hutton M., de Silva R., Lees A., and Dickson D.W. Argyrophilic grain disease is a sporadic 4-repeat tauopathy. J. Neuropathol. Exp. Neurol. 61 6 (2002) 547-556
71. Trinczek B., Biernat J., Baumann K., Mandelkow E.M., and Mandelkow E. Domains of tau protein, differential phosphorylation, and dynamic instability of microtubules. Mol. Biol. Cell 6 12 (1995) 1887-1902
72. Urak L., Feucht M., Fathi N., Hornik K., and Fuchs K. A GABRB3 promoter haplotype associated with childhood absence epilepsy impairs transcriptional activity. Hum. Mol. Genet. 16 (2006) 2533-2541
73. Varani L., Hasegawa M., Spillantini M.G., Smith M.J., Murrell J.R., Ghetti B., Klug A., Goedert M., and Varani G. Structure of tau exon 10 splicing regulatory element RNA and destabilization by mutations of frontotemporal dementia and parkinsonism linked to chromosome 17. Proc. Natl. Acad. Sci. U. S. A. 96 14 (1999) 8229-8234
74. Varela M.C., Krepischi-Santos A.C., Paz J.A., Knijnenburg J., Szuhai K., Rosenberg C., and Koiffmann C.P. A 17q21.31 microdeletion encompassing the MAPT gene in a mentally impaired patient. Cytogenet. Genome Res. 114 1 (2006) 89-92
75. Yan H., Yuan W., Velculescu V.E., Vogelstein B., and Kinzler K.W. Allelic variation in human gene expression. Science 297 5584 (2002) 1143
76. Yoshida H., Crowther R.A., and Goedert M. Functional effects of tau gene mutations deltaN296 and N296H. J. Neurochem. 80 3 (2002) 548-551